PMC:7560789 / 5235-5431 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T42","span":{"begin":31,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T43","span":{"begin":45,"end":52},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T44","span":{"begin":117,"end":123},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T45","span":{"begin":147,"end":151},"obj":"http://purl.obolibrary.org/obo/CLO_0001625"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T73","span":{"begin":42,"end":44},"obj":"Chemical"},{"id":"T75","span":{"begin":68,"end":71},"obj":"Chemical"},{"id":"T76","span":{"begin":106,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A73","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A74","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A76","pred":"chebi_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A77","pred":"chebi_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T46","span":{"begin":0,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T6","span":{"begin":42,"end":44},"obj":"GlycoEpitope"}],"attributes":[{"id":"A6","pred":"glyco_epitope_db_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T32","span":{"begin":106,"end":109},"obj":"Phenotype"}],"attributes":[{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"137","span":{"begin":42,"end":44},"obj":"Chemical"}],"attributes":[{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:C012990"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Based on clinical symptoms and a positive GM testing on nondirected BAL fluid, the proportion of putative IPA in the tested cohort was 21.4%, with a 95% confidence interval of 9.0–33.8% (Table 2)."}